Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
GLP-1
Biotech
Ph. 2 data will drive biopharma VC investment in 2025: PitchBook
Phase 2 trial data will continue to be the name of the game when it comes to VC investments into biopharma in 2025, according to PitchBook.
James Waldron
Dec 23, 2024 4:33am
Merck pays $112M upfront for Hansoh's preclinical GLP-1
Dec 18, 2024 7:44am
Antag secures $84M series A for GLP-1 add-on
Dec 4, 2024 3:00am
Amgen obesity drug matches competition but investors unimpressed
Nov 26, 2024 10:11am
Versant unveils Pep2Tango, a biotech with next-gen obesity hopes
Nov 21, 2024 11:11am
Metsera follows phase 1 weight loss data with $215M series B
Nov 13, 2024 9:15am
